PharmaShots | Incisive News in 3 Shots

Subscribe Now

Endometrial Cancer

Roche Receives the US FDA's Approval for First CDx to Identify Endometrial Cancer Patients Eligible for Immunotherapy

Roche Receives the US FDA's Approval for First CDx to Identify Endometrial Cancer Patients Eligible for Immunotherapy

April 23, 2021

GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Approval for dMMR Endometrial Cancer

GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Approval for dMMR Endometrial Cancer

April 23, 2021

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment of Advanced Endometrial Cancer at SGO

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment o...

March 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us